- $3.04bn
- $4.98bn
- $2.13bn
- 48
- 65
- 100
- 82
Annual income statement for Marex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 January 1st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 829 | 981 | 1,761 | 2,130 |
| Cost of Revenue | ||||
| Gross Profit | 487 | 470 | 588 | 743 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 783 | 1,055 | 2,158 | 2,602 |
| Operating Profit | 45.5 | -74.3 | -397 | -472 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 69.9 | 122 | 197 | 296 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 56.5 | 98.2 | 141 | 218 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 56.5 | 98.2 | 141 | 218 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 56.5 | 91.6 | 128 | 205 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.798 | 1.09 | 1.97 | 2.81 |
| Dividends per Share |